According to Merck's latest financial reports the company's current EPS (TTM) is $6.90. In 2024 the company made an earnings per share (EPS) of $6.76 an increase over its 2023 EPS that were of $0.15.
Year | EPS | Change |
---|---|---|
2025 (TTM) | $6.90 | 2.04% |
2024 | $6.76 | 4308.46% |
2023 | $0.15 | -97.32% |
2022 | $5.73 | 10.92% |
2021 | $5.17 | 84.68% |
2020 | $2.80 | -27.2% |
2019 | $3.84 | 63.44% |
2018 | $2.35 | 151.11% |
2017 | $0.94 | -54.58% |
2016 | $2.06 | 30.21% |
2015 | $1.58 | -61.99% |
2014 | $4.16 | 180.51% |
2013 | $1.48 | -31.82% |
2012 | $2.18 | 6.62% |
2011 | $2.04 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Pfizer PFE | $1.39 | -79.85% | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | $9.07 | 31.47% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $12.36 | 79.14% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | $2.68 | -61.14% | ๐บ๐ธ USA |
![]() Sanofi SNY | $2.85 | -58.72% | ๐ซ๐ท France |
![]() GlaxoSmithKline GSK | $1.56 | -77.39% | ๐ฌ๐ง UK |
![]() Teva Pharmaceutical Industries TEVA | -$1.14 | -116.53% | ๐ฎ๐ฑ Israel |
![]() Novartis NVS | $6.43 | -6.78% | ๐จ๐ญ Switzerland |
![]() Abbott Laboratories ABT | $7.79 | 12.90% | ๐บ๐ธ USA |
![]() Amgen AMGN | $11.05 | 60.21% | ๐บ๐ธ USA |